Skip to Main Content

INFORMATION FOR

Effects of Psilocybin in Concussion Headache

Conditions

Diseases of the Nervous System | Mental Health & Behavioral Research | Pain Control

What is the purpose of this trial?

The purpose of this study is to investigate the effects of oral psilocybin in post-traumatic headache. Subjects will be randomized to receive placebo, low dose psilocybin, or high dose psilocybin on two separate test days approximately 14 days apart. Subjects will maintain a headache diary prior to, during, and after the treatments in order to document headache frequency and intensity, as well as associated symptoms. Blood samples will be drawn at various timepoints to measure levels of inflammatory peptides.

  • Trial with
    CH TAC, LLC
  • Start Date
    10/27/2016
  • End Date
    06/30/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #1607018057